September, 2019
Dr. Leftin and collaborator Dr. Chuan Huang receive Carol M. Baldwin Breast Cancer Foundation Award for metabolic imaging in cancer immunotherapy. 

May, 2019
Dr. Leftin joins Stony Brook University as
Bahl Center for Metabolomics and Imaging Asssitant Professor.

Biology through the lens of magnetic resonance.  Since the early days of magnetic resonance, the field has been split along two general lines.  (1)  Nuclear magnetic resonance (NMR) that provides atomic resolution of biomolecular structure and dynamics in vitro, and (2) magnetic resonance imaging (MRI) that provides whole-body information about physiology in vivo.  The central goal of the Laboratory is to fulfill the vision of integrating these two disciplines to enable systems-to-molecule investigations of molecular biophysics in vivo.  As part of the Bahl Center for Metabolomics and Imaging in the Stony Brook Cancer Center our multidisciplinary team focuses their efforts in translational magnetic resonance imaging and spectroscopy technology development and cutting-edge preclinical cancer research to advance our understanding of cancer prevention, progression, and therapeutic response.

Our current Research interest is in applying magnetic resonance to investigate the intersection of iron and lipids in cancer and specifically dissect the role of these biomolecules in immune response. Please see our “Publications” for more information.

We have ample opportunities ranging from biomedical engineering to pharmacology to structural biology for students of diverse research backgrounds and interests to explore. 

Please Contact Us for information about joining the Laboratory.